General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
The Efficacy of Involuntary Outpatient Treatment in Massachusetts.
Geller, J., Grudzinskas, A.J. Jr., McDermeit, M., Fisher, W.H., and Lawlor, T. (1998).
Administration and Policy in Mental Health 25:3. 271- 285.
COMPARISON OF ADMISSIONS DATA FOR IOT AND CTS GROUPS
The purpose of this Massachusetts study was to learn whether IOT was effective in reducing the number of psychiatric admissions and inpatient days for patients who in the past had an excessive use of inpatient treatment. Nineteen patients with court orders for IOT were matched with CTS data from the Massachusetts Department of Mental Health that provided information on the demographic, clinical, and utilization of services for clients statewide. First the researchers matched the IOT patients using demographic data. Researchers also matched the 19 IOT patients with other clients according to inpatient service use (ISU). The following comparisons were made:
1. Pre-treatment data with post-treatment data for IOT;
2. Pre-treatment data with post-treatment data for CTS Demographic and
ISU patients (All and Best Matches); and
3. Post-treatment data for IOT with CTS Demographic and ISU (All and
Best Matches))
Based on these comparisons, the researchers evaluated whether the IOT group after treatment showed a greater decrease in number of admissions and inpatient days as compared to the CTS and ISU study groups. Results indicated that the IOT group showed significantly greater decreases in number of admissions and days than did either the All/Best Demographic groups. The IOT patients went from 1.63 to .58 admissions, a decrease of 1.05 and from 112.73 to 44.3 days, a decrease of 68.43. The All Demographic matched group went from .49 to .21 admissions, a decrease of .28, and from 19.42 to 22.1 days, a gain of 2.68 days. The Best Demographic group demonstrated a .1 decrease in admissions (.21 to .11) and a 3.7 decrease in days (15.1 to 11.4). However, when IOT was matched according to inpatient use, the groups were statistically similar in their decreases in number of admissions and days following treatment. The IOT decrease in number of admissions was 1.05 compared to a .85 decrease for ISU All and a 1.05 decrease for ISU Best; IOT decrease in number of days was 68.43 compared to 50 for ISU All and 47.8 for ISU Best.
Researchers concluded, "The results of this analysis are unfortunately equivocal. The trends observed in our data seem to suggest that IOT has had an effect, particularly with respect to reduced use of hospital days that was less pronounced for patients not under an IOT order. But these differences did not achieve statistical significance" (p. 282).
Researchers indicated that the small sample size of this study would yield low statistical power. Observed trends indicating differences in the groups might achieve statistical significance with a larger sample size (p. 282).
SUMMARY
Nineteen patients in IOT were matched with CTS clients on gender, diagnosis, age, and the quarter of the year they first appeared in CTS. The number of admissions and hospital days were compared for the same two 6-month periods both before and after treatment. The number of admissions and number of inpatient days for the IOT clients were compared with all matching CTS patients and also with the best single match. In addition to demographic matching, the researchers matched the 19 IOT patients with other patients according to inpatient service use (ISU) during the pre-treatment period using the all and best match strategy. Figure 1 displays the recorded data.
Figure 1: IOT Data Compared to Demographic (CTS) and Inpatient Service Usage (ISU) Matched Groups
Variables | IOT (N=19) |
Demographic (CTS) Matches | Inpatient Service Use (ISU) Matches | ||
All (N=53) |
Best (N=19) |
All (N=38) |
Best (N=19) |
||
Age | 38.5 years | 37.6 years | 38.5 yrs. | 45.6 yrs. | 43.4 |
Gender (male) | 63% | 68% | 63.2% | 55.3 % | 58% |
Diagnosis | 58% schizophrenic | 70% schizophrenic | 57.9% schizophrenic | Not given | Not given |
Avg. start date | 7/93 | 5/93 | 11/92 | 8/92 | 8/92 |
Pre-treatment: # admissions |
1.63 | .49 | .21 | 1.53 | 1.63 |
Pre-treatment: # days |
112.73 | 19.42 | 15.1 | 119.9 | 111.9 |
Post-treatment: # admissions |
.58 | .21 | .11 | .68 | .58 |
Post-treatment: # days |
44.3 | 22.1 | 11.4 | 69.9 | 64.1 |